Infliximab therapy inpatients with ankylosing spondylitis: An open label study on efficacy and safety

被引：0
|
作者：
Macieira, C [1 ]
Costa, M [1 ]
Ramos, F [1 ]
Sequeira, G [1 ]
Castelao, W [1 ]
de Queiroz, MV [1 ]
机构：
[1] Hosp Santa Maria, Dept Rheumatol, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [1] Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study
    Temekonidis, TI
    Alamanos, Y
    Nikas, SN
    Bougias, DV
    Georgiadis, AN
    Voulgari, PV
    Drosos, AA
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (12) : 1218 - 1220
  • [2] Open label study of Infliximab (remicade) in refractory ankylosing spondylitis (AS).
    Luongo, R
    Maksymowych, WP
    Lambert, RW
    Russell, AS
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (06) : 1420 - 1420
  • [3] A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
    Anna Rita Giardina
    Angelo Ferrante
    Francesco Ciccia
    Rosalia Impastato
    Maria Concetta Miceli
    Alfonso Principato
    Giovanni Triolo
    Rheumatology International, 2010, 30 : 1437 - 1440
  • [4] A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
    Giardina, Anna Rita
    Ferrante, Angelo
    Ciccia, Francesco
    Impastato, Rosalia
    Miceli, Maria Concetta
    Principato, Alfonso
    Triolo, Giovanni
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1437 - 1440
  • [5] THE EFFICACY AND SAFETY OF INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF AN OPEN-LABELED MULTICENTER STUDY
    Bunchuk, N. V.
    Rumyantseva, O. A.
    Loginova, E. Yu
    Bochkova, A. G.
    Storozhakov, G. I.
    Ettinger, O. A.
    Kosyura, S. D.
    Kamalova, R. G.
    Valishina, L. M.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (10) : 41 - 46
  • [6] Efficacy of infliximab in refractory ankylosing spondylitis:: results of a six-month open-label study
    Breban, M
    Vignon, E
    Claudepierre, P
    Devauchelle, V
    Wendling, D
    Lespessailles, E
    Euller-Ziegler, L
    Sibilia, J
    Perdriger, A
    Mezières, M
    Alexandre, C
    Dougados, M
    RHEUMATOLOGY, 2002, 41 (11) : 1280 - 1285
  • [7] Efficacy of infliximab in subgroups of patients with ankylosing spondylitis: Results from the ankylosing spondylitis study for the evaluation of recombinant infliximab therapy (ASSERT)
    Braun, J
    Maksymowych, WP
    Dougados, M
    Steinfeld, S
    Dewoody, K
    Williamson, P
    Van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
  • [8] The efficacy of infliximab in ankylosing spondylitis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2004, 6 (2) : 96 - 96
  • [9] A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
    Kobayashi, Shigeto
    Harigai, Masayoshi
    Mozaffarian, Neelufar
    Pangan, Aileen L.
    Sharma, Shringi
    Brown, L. Steven
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 589 - 597
  • [10] EFFICACY AND SAFETY OF LOW-DOSE INFLIXIMAB IN ANKYLOSING SPONDYLITIS
    Schaufelberger, C.
    Morck, B.
    Jacobsson, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 642 - 643
12345